Cargando…
Clevudine Induced Mitochondrial Myopathy
Clevudine was approved as an antiviral agent for hepatitis B virus, which showed marked, rapid inhibition of virus replication without significant toxicity. However, several studies have reported myopathy associated with clevudine therapy. Also, we experienced seven patients who suffered from myopat...
Autores principales: | Park, Soo-Hyun, Park, Kyung-Seok, Kim, Nam-Hee, Cho, Joong-Yang, Koh, Moon Soo, Lee, Jin Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639069/ https://www.ncbi.nlm.nih.gov/pubmed/28960041 http://dx.doi.org/10.3346/jkms.2017.32.11.1857 |
Ejemplares similares
-
Efficacy of Initial Treatment with Clevudine in Naive Patients with Chronic Hepatitis B
por: Yang, Hyeon Woong, et al.
Publicado: (2010) -
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
por: Cho, Eun Young, et al.
Publicado: (2017) -
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
por: Tak, Won Young, et al.
Publicado: (2014) -
Long-Term Treatment Efficacy and Safety of Clevudine Therapy in Naïve Patients with Chronic Hepatitis B
por: Choung, Bum Su, et al.
Publicado: (2012) -
High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells
por: Jang, Yoon-Ok, et al.
Publicado: (2012)